Decitabine Impurity 36 | CAS 178671-74-4 - Request Quote
Decitabine Impurity 36
| SZ CAT No: | SZ-D019058 |
| CAS No | 178671-74-4 |
| Mol.F. | C7H14N4O4 |
| Mol.Wt. | 218.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Decitabine Impurity 36 is chemically Urea, N-(aminoiminomethyl)-N'-(2-deoxy-α-D-erythro-pentofuranosyl)-. Decitabine Impurity 36 is supplied with detailed characterization data compliant with regulatory guideline. Decitabine Impurity 36 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Decitabine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 178671-74-4
Purchase 178671-74-4
Order 178671-74-4
Enquire 178671-74-4
price of 178671-74-4
178671-74-4 Supplier
178671-74-4 Manufacturer
178671-74-4 Exporter
buy high quality Decitabine Impurity 36
Purchase Decitabine Impurity 36
Decitabine Impurity 36 suppliers
Decitabine Impurity 36 manufacturers
Decitabine Impurity 36 price
Order Decitabine Impurity 36
Enquire Decitabine Impurity 36
Decitabine Impurity 36 cost
Decitabine Impurity 36 Supplier
Decitabine Impurity 36 Distributor
Decitabine Impurity 36 for Method Validation
Decitabine Reference Standard
Decitabine Impurity 36 for ANDA Filing
Decitabine Impurity 36 for Forced Degradation Studies
Decitabine Impurity 36 Identification Standards
Decitabine Impurity 36 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.